Genscript Technology (Nanjing) Co., Ltd. (金思特科技) is an experimental platform that focuses on biological technology.

It is a comprehensive biological technology service corporation and the biggest bio-medical CRO established in 2004. Genscript Technology has about 600 workers, among whom more than 80% have the college and higher education background and about 30% of the employees have master degrees or above. The American technical directors in all departments of the company have PhD degrees or above, and have many years of research and management experience; 40% management staff have management and scientific research experiences in enterprises of biological medicine field for 5-15 years.

Since the foundation, Genscript Technology has established 6 experimental platforms: gene synthesis, PCR cloning, construction of siRNA, polypeptide synthesis, protein expression, and purification, as well as antibody preparation. The scope of services includes one-stop service from genes to antibodies, and biotechnology services for bioengineering, and new drug screening of early development.

Contact Information

Nanjing
China

Overview

Total FundingEmployeesLast Funding DateStatus
$15,000,000unknown2009-05-01Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2009-05-01$15,000,000Series UnknownKleiner Perkins